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ABSTRACT
Objective: On the basis of traditional use and Ethno pharmacological evidences Boerhavia diffusa whole plant and root part of Asparagus racemosus 
(Shatavari) both are widely used to enhance the immunity. But in combination there is no scientific evidence so current study was designed.
Methods: Laboratory based study, namely, carbon clearance, cyclophosphamide induced immune suppression and neutrophil adhesion was designed 
using mice as an experimental animals in different combination of aqueous whole plant extract of B. diffusa and methanol extract of root part of A. 
racemosus were used as a test drug in the ratio 1:1, 1:2, and 2:1 (100 mg/kg) against the established standard drug Ashwagandha.
Results: The results revealed that animals treated with combined extract (1:1, 1:2, and 2:1) at a dose of 100 mg/kg increase rate of carbon clearance 
from blood, there is significance alternation in blood parameter in cyclophosphamide group and also improve the Neutrophil adhesion when treated 
with different combination of polyherbal formulation treated groups.
Conclusion: The polyherbal formulation in different ratio showing good significant immunomodulatory activity as compare to standard.
Keywords: Immunomodulation, Carbon clearance, Neutrophil adhesion, Synergism.
INTRODUCTION
Plants are an indispensable part of nature. They are composed with a 
specific purpose. Nature throws back the creative powers of a living 
supreme being. Nature always perches as a golden mark to represent 
the outstanding phenomena of symbiosis.
Herbal drugs are the major cure in traditional system of medicine. The 
practices continue in today’s modern world because of its biomedical 
benefits as well as its place in traditional beliefs in many parts of world, 
have made a great contribution towards maintaining mankind [1]. It 
was found that almost 121 pharmaceutical products were formulated 
based on the traditional knowledge obtained from various sources [2].
Ayurveda, the ancient Indian traditional system of medicine 
lays significance on promotion of health for cure of diseases and 
strengthening of both physical and mental health [3]. The present 
work was done on the Boerhavia diffusa whole plant on the basis of 
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the literature obtained from the Ethno medicinal documentation. The 
common name is Punarnava. Keeping in view the tremendous ethno 
medicinal use of B. diffusa it was aimed to scientifically validate the 
immune modulatory property of the root part of B. diffusa.
In combination with root part of Asparagus racemosus commonly 
known as Shatavari (A. racemosus). The plant has tiny white flowers, 
in small spikes. The roots are finger-like and clustered, and in tropical 
climates throughout India, Asia, Australia, and Africa [4].
In view of the above, the present investigation was undertaken to 
evaluate the immunostimulatory potentiality of B. diffusa and A. 
racemosus the ratio is 1:1, 1:2, and 2:1 the both by in vivo model system 
based on the evidence of ethno medicinal use of these plants in such 
diseases of immune suppression state in Kolkata.
METHODS
Plant materials
Ethanolic extract of the whole parts of B. diffusa and the aqueous extract of 
the root part of A. racemosus were used as test drug in these experiments. 
Plants were authenticated by Botanical Serve of India, Shibpur, Howrha, 
West Bengal India, Specimen no-CNH/26a/2012/Tech.II/7006.
Test compound formulations
Oral suspensions of the root and whole plant extract were prepared by 
suspending them in 1% solution of sodium carboxy methylcellulose to 
obtain suitable dosage forms the ratio of A. racemosus and B. diffusa 
(1:1, 1:2, and 2:1), respectively.
Animal used
Male Swiss albino mice weighing 18–22 g were taken. They were 
obtained from the institutional animal house, NSHM, Kolkata, India. The 
mice were grouped and housed in poly- acrylic cages (38 × 23 × 10 cm) 
with six animals per cage and maintained under standard conditions 
with (temperature 25±2°C and dark/light cycle 14/10 h). They were 
allowed to have free access to dry pellet diet and water ad libitum. The 
mice were habituate to laboratory conditions for 7 days before start of 
the experiment. All procedures described were viewed and approved 
by the Institutional Animal Ethical Committee.
Drugs and chemicals
EDTA, Phosphate buffered saline, sodium carbonate, solution, (Endoxan 
Injection German Remedies, India) Indian ink, Carboxy methyl cellulose 
(CMC), Cyclophosphamide 30 mg/kg b.w., and Ashwagandha 50 mg/kg b.w.
In vivo carbon clearance test 
Mice were divided into four groups, each containing ten animals. 
Group I (Control) was given normal saline for 7 days, Groups II 
and III were administered different ratio of the methanol extract 
(50–100 mg/kg, p.o.), and Group IV was administered standard 
drug Ashawagandha 50 mg/kg, p.o.). At the end of 7 days, mice of 
all the groups were injected through the tail vein the carbon ink 
suspension (10 μl/g body weight). Blood samples were drawn (in EDTA 
solution 5 μl) from the cardiac puncture at intervals of 0 and 15 min, 
a 25 μl sample was mixed with 0.1% sodium carbonate solution of 2 ml 
and their absorbance was measured at 660 nm. The carbon clearance 
was calculated using the equation: (Loge OD1–Loge OD2)/15 where as 
OD1 and OD2 are the optical densities at 0 and 15 min, respectively [5].
Cyclophosphamide induced immunosuppression [6]
Dose calculation: Ethanolic extract of the whole parts of B. diffusa and 
the aqueous extract of the root part of A. racemosus were used as test 
drug the ratio is 1:1, 1:2, and 2:1 (100 mg/kg).
Treatment
Animals were divided into the six groups containing six animals in 
each group. Group1 (Control group) received CMC for 14 days and 
Group 2 (Challenge group) received CMC for 10 days, on 11th, 12th, and 
13th day cyclophosphamide intraperitonially at a dose of 30 mg/kg b/w. 
Groups 3, 4, and 5 (Test group) received poly herbal formulation of 
extract (1:1, 1:2, and 2:1) at a dose of 100 mg/kg body weight orally for 
14 days. On 11, 12, and 13th days, cyclophosphamide solution was given 
intraperitonially at a dose of 30 mg/kg b/w 1 h after the administration 
of the extract. Group 5 received the standard drug.
Hematological test
After the treatment, animals were light anaesthetized by using di-ethyl 
ether. The blood was collected from the cardiac puncture using heparin 
containing capillary tubes and hematological tests were carried 
out for white blood cell (WBC) count red blood cell (RBC) count and 
hemoglobin content.
Neutrophil adhesion test [7]
Total leukocyte counts (TLC) and differential leukocyte counts (DLC) 
both were studied by fixing the blood smears and staining it with 
Field stain I and II- Leishman’s stain, blood samples were incubated 
with 80 mg/ml of nylon fibers for 15 min at 37°C. Incubated samples 
were then again analyzed for TLC and DLC. The result of TLC and % 
neutrophil gives neutrophil index (NI) of blood sample. % of the 
neutrophil adhesion was calculated as shown below
Neutrophil adhesion can be calculated
NI u – NI t × 100/NI u
Whereas,
NI u =NI of the untreated blood samples.
NI t = NI of the treated blood samples.
RESULTS
The results are presented in Table 1 showed the immune stimulatory 
activity of poly herbal formulation in mice. The results revealed that 
Table 1: In vivo carbon clearance test
Group number Treatment mg/kg Carbon clearance
I Control 0.069±0.014
II Extract (1:1) 100 0.094±0.014 *
III Extract (1:2) 100 0.139±0.17*
IV Extract (2:1) 100 0.135±0.27*
V Ashwagandha 50 0.158±0.014
Figure 1 : Effect of poly herbal formulation at various ratio 
on cyclophosphamide induces neutrophils adhesion. All data 
were expressed as mean ± SEM (n = 6). Where **p < 0.0001 
(with respect to Normal) and *p < 0.001(with respect to 
cyclophosphamide) are considered to be highly significant and 
significant.
122
Asian J Pharm Clin Res, Vol 14, Issue 11, 2021, 120-123
 Kumari et al.
animals treated with combined extract (1:1, 1:2, and 2:1) at a dose of 
100 mg/kg increase rate of carbon clearance from blood. Administration 
of test drug 100 mg/kg resulted in significant increase in the rate of 
carbon clearance compared with control group. On the other hand, the 
rate of carbon clearance value of 1:2 ratio was found to be slightly lower 
than that of the standard compound Ashwagandha. The effectiveness 
against chemical-induced immunosuppression after Administration of 
Cyclophosphamide (30 mg/kg, i.p) produced a significant decrease in 
the total leukocyte. The count is from 6.2±0.081 to 3.08±0.214, and the 
RBC count from 4.91±0.116 to 2.9±0.152, and % of hemoglobin (hb) 
from 16.60±0.081 to 10.32±0.153 (p<0.01) (Table 2). It was found to 
be consistent with earlier studies which state that cyclophosphamide 
induces immune dysfunction through reactive intermediate- induced 
damage to the cells of the immune system [8]. Evaluation of effect of 
the ethanol extract of the whole parts of B. diffusa and the aqueous 
extract of the root part of A. racemosus were used as test drug in these 
experiments on cyclophosphamide induced immune suppression 
indicated good protection by increasing all the hematological 
parameters. WBC count, RBC count, and % hb values observed were 
better than untreated control groups.
Neutrophil adhesion test
This test is an indicative of the marginalization of phagocytic cells 
in the blood vessels, i.e. an indication of immune stimulation. The % 
neutrophil adhesion in control group animals was, 34.5±1.7 in CP 
treated group was 14.74±2.46 in 1:1 treated group it was 21.25±2.78, 
1:2 is 30.50±1.70, 2:1 is 30±1.29 and standard 32.25±1.79 (Fig. 1). The 
results of neutrophil adhesion test indicating that there was significant 
(p<0.05) increase in neutrophil adhesion after administration of poly 
herbal extract at various ratio when compare to cyclophosphamide 
treated groups.
Statistical analysis
All the data are given as the mean±SEM of three individual 
measurements. Data on all the experiment were analyzed using analysis 
of variance (ANOVA) and the group means were compared by Dunnett’s 
by Graph Pad Prism software, version 4.03. A probability of p<0.05 was 
considered as significant.
Statistical significance (p) calculated by one-way ANOVA between 
Cyclophosphamide control group and the treated groups followed by 
Dunnett’s test (**p<0.05). Each point represents the mean±SEM (n=6 
mice per groups).
Cyclophosphamide, Test drug-Combined poly herbal formulation of 
B. diffusa and A. racemosus (1:1), (1:2) and (2:1) Std.drug- Standard 
drug. Statistical significance (p) calculated by one-way ANOVA 
between cyclophosphamide control group and the treated groups 
followed by Dunnett’s test (**p<0.05). Each point represents the 
mean±SEM (n=6 mice per groups).
DISCUSSION
Immunity is the ability of the body to defend itself against specific 
invading agents such as bacteria, toxins, viruses and foreign tissues [9]. 
An immunomodulator is any substance that helps to regulate the 
immune system. This “regulation” is a normalization process, so that 
an immunomodulator helps to optimize immune response. Immune 
dysfunction is responsible for various diseases like ulcerative colitis, 
asthma, allergy, cancer and infectious diseases [10]. The extend up 
to which the patient becomes abnormally susceptible to infections 
by environment depends on the extent of immunosuppression. This 
immunosuppression allows pathogens to submerge the host to cause 
secondary infection [11]. This problem can be overcome by boosting 
the immune system by the use of immunomodulatory drugs [12]. Many 
medicinal plants are known to have immunomodulatory properties 
and maintain organic resistance against infection by re- establishing 
the body’s immune system such as Azadirachta indica [13] Terminalia 
chebula [14] Lawsonia alba [15]. The phytochemical constituents such 
as diterpenoids, steroids, proteins, and tannins [16] are considered to 
exhibit immunomodulatory property.
The use of medicinal plants to cure human illnesses has been 
practiced from time immemorial. Some of these drugs are believed to 
enhance the natural resistance of the body to infection [17]. In fact, 
one of the therapeutic strategies in Ayurvedic medicine is to provide 
protection by increasing body’s resistance to disease [18]. The idea 
of immunomodulation refers to a non-specific trigger to the immune 
system. It implies non-antigen dependent activation of the function 
and efficiency of macrophages, granulocytes, complement, natural 
killer cells, lymphocytes, and also the production of various effector 
molecules by activated cells (paraimmunity). After being non-specific, 
it is highly expected to provide protection against different pathogens 
including bacteria, fungi, viruses, etc., and add upto another or adjunct 
to conventional chemotherapy.
The present study is aimed at studying the immunomodulatory 
properties of two selected immunomodulator plant at different ratio. In 
this study, we report on the effect of combined polyherbal formulation 
on different aspects of immunity such as carbon clearance from blood, 
total RBC, WBC count, and Hb content neutrophils adhesion test.
Phagocytosis act for as an important innate defense mechanism against 
devour foreign materials [10]. In the following carbon clearance test, 
rate of clearance of carbon from blood by phagocytic cells is governed 
by phagocytic index(K). In this study an increased in phagocytic index 
at administration of poly herbal formulation at different ratio, but 
the 1:2 ratio shown the very good result. The phagocytic index of 1:2 is 
near about standard drug Ashwagandha. The increased level carbon 
clearance from blood is may be due to the increased production of 
phagocytic cell stimulated by administration of poly herbal formulation 
at different ratio.
Bone marrow is a site of continued proliferation and turnover of blood 
cells and is a source of cells involved in immune activity. Bone marrow 
is the organ most affected during any immunosuppression therapy 
with this class of drugs. Loss of stem cells and inability of bone marrow 
to regenerate new blood cells will result in thrombocytopenia and 
leucopenia [10]. Immune activation is an effective as well as protective 
approach against emerging infectious diseases [19].
Immunomodulatory activity of poly herbal formulation at different 
ratio was explored by evaluating their effects on cyclophosphamide 
induced bone marrow suppression in mice at combined at formulation 
of three ratio at 100 mg/kg dose levels. Results of the study revealed 
the ratio dependent counteracting effect of the extracts to the 
cyclophosphamide induced bone marrow activity suppression, 
that is, myelosuppression, as indicated by increase in RBC, total 
WBC platelet counts, Hb%, and DLC in the test drug treated groups 
(Groups III, IV, V, and VI), when compared to cyclophosphamide treated 
group (Group II). The potentiated activity of test drug may be due to 
presence of flavonoids, alkaloids, tannins, and steroids. The results 
Table 2: Haematological Parameter
Parameters Normal saline 
(5ml/kg)








RBC (cell×106/mm3) 6.29±0.20 4.63±0.09 4.83±0.08 5.53±0.25** 5.19±0.20** 5.19±0.20**
WBC (cell×103/mm3) 4.98±0.32 2.84±1.13 3.70±0.62** 4.25±0.65** 4.09±0.33** 5.09±0.33**
Hb. (g/dL) 11.48±0.38 6.23±0.14 7.9±0.12** 10.35±0.21** 8.4±0.46** 10.75±0.46**
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shows the modulation of bone marrow activity, namely, – suppression 
when used cyclophosphamide alone and stimulation to counteract the 
cyclophosphamide induced myelosuppression in pretreated with test 
drug and standard drug.
CONCLUSION
After performing the experiment by the ethanolic extract of whole plant of 
B. diffusa and aques extract of A. racemosus root part having the three ratio 
1:1, 1:2, and 2:1, respectively, (100 kg/body wt) the combined effect of 
ethanolic extract of B. diffusa and aqueous extract of A. racemosus having 
ratio 1:2 is found effective. However this is a preliminary research work 
and the precise mechanism(s) of immunomodulatory action influenced 
by potent bio-active constituents of ethanolic and aqueous extracts of root 
and whole plant of B. diffusa and A. racemous against cyclophosphamide 
induced immunesuppression needs to be investigated.
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